-
Mashup Score: 2FDA Grants 510(k) Clearance to Sebia’s FLC Kappa, Lambda Assays for MM Diagnosis | Blood Cancers Today - 10 day(s) ago
Sebia’s free light chain (FLC) kappa and lambda assays have 510(k) clearance.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
A single question can be used to predict early treatment discontinuation in patients with multiple myeloma, a study suggests.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
After cancer, I’ve been learning to maintain a positive attitude regarding my self-image and rehabilitation.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 4Cilta-Cel Approved for Expanded Use in Patients with Relapsed or Refractory Multiple Myeloma | Blood Cancers Today - 30 day(s) ago
Cilta-cel was previously approved by the FDA in relapsed or refractory MM after four or more prior lines of therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 25Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi | Blood Cancer Talks | Episode 43 - 1 month(s) ago
In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi from University of Arkansas Myeloma Center. RCTs of BCMA CAR T-cell Therapy in Early Relapsed Multiple Myeloma:a) KarMMa-3 (ide-cel):…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9Ide-Cel Approved by European Union for MM | Blood Cancers Today - 2 month(s) ago
The approval was based on results from the KarMMa-3 study, which compared ide-cel with standard combination regimens.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Taking Control of Diet May Improve Outcomes for Multiple Myeloma - 2 month(s) ago
Eating a plant-based diet has been associated with sustained MRD negativity for patients with multiple myeloma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 8Multiple myeloma: Its evolution, treatment and the quest to catch it early - Mayo Clinic News Network - 2 month(s) ago
March is Multiple Myeloma Awareness Month. Multiple myeloma is a cancer of a type of white blood cell called a […]
Source: newsnetwork.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
There's no shortage of FDA news this week on BCT! The @US_FDA has granted 510(k) clearance to @SebiaUS's FLC kappa and lambda assays to aid in the diagnosis and monitoring of #MultipleMyeloma and AL amyloidosis. 📰 Read more: https://t.co/LzzYfWxg8h https://t.co/nxXTNzACMP